CDK4/6 is crucial for the G1- to S-phase transition and abnormalities in CDK4/6 and the NF1 (a negative regulator of RAS activity) gene may contribute to neuroblastoma and malignant peripheral nerve sheath tumors. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.